Seven studies (Golan et al. 2014; Oettle et al. 2014; Kaufman et al. 2015; Wu et al. 2015; Hurt et al. 2017; Kobayashi et al. 2017; Xu et al. 2017) that investigated a predictive role of BRCA1 or 2 mutation among patients with pancreatic cancer are summarized in Table 1. This evidence concerns the gene BRCA1 and pancreatic neoplasm.